- Use of intention-to-treat analysis |
- Age |
- Use of tDCS with a combined intervention |
- Size of intervention groups |
- Duration of symptoms |
- Type of combined intervention |
- Dropouts in intervention groups |
- Gender |
- Timing of combined intervention |
- Disease diagnostic definition criteria |
- Race |
- Total number of intervention sessions |
- Blinding of study subject |
- Body mass index |
- Frequency of intervention sessions per week |
- Blinding of intervention staff |
- Number of subjects with another chronic illness |
- Duration of tDCS intervention in weeks |
|
- Baseline depression level |
- Patient setting |
|
- Baseline anxiety level |
- Type of tDCS montage |
|
- Baseline pain catastrophizing score |
- Number of stimulation channels |
|
- Percentage of subjects using opioids |
- Stimulation polarity |
|
- Percentage of subjects using gabapentinoids |
- Active electrode location |
|
- Percentage of subjects using antidepressants |
- tDCS current intensity parameter (mA) |
|
- Percentage of subjects using anticonvulsants |
- tDCS session duration |
|
- Percentage of subjects using analgesics |
- tDCS electrode surface area |
|
- Percentage of subjects using myorelaxants |
|
|
- Disability score at baseline |
|
|
- Sleep quality score at baseline |
|
|
- Baseline pain Level (Active and Sham groups) |
|